Literature DB >> 2351708

Assisted fertilization in infertile women with patent fallopian tubes. A comparison of in-vitro fertilization, gamete intra-fallopian transfer and tubal embryo stage transfer.

T Tanbo1, P O Dale, T Abyholm.   

Abstract

A comparison of the relative efficacy of in-vitro fertilization with uterine embryo transfer (IVF), tubal embryo stage transfer (TEST) and gamete intra-Fallopian transfer (GIFT) was performed in infertile patients with patent Fallopian tubes. A total of 150 couples with unexplained infertility, peritoneal endometriosis or reduced semen quality were included in the study. The three groups were comparable with regard to age distribution, indications, semen parameters, stimulation regimens, response to stimulation and numbers of oocytes retrieved. In the IVF and TEST groups there was no cleavage in 24% and a cleavage rate of only 47.6%. The highest cleavage rate was obtained in the endometriosis patients. The pregnancy rate was highest in the two groups in which in-vitro fertilization was performed, IVF = 45.7%, TEST = 37.9%, GIFT = 26.2%. To obtain one live intrauterine fetus, more oocytes had to be transferred in the GIFT group compared to the number of embryos in the IVF group, 14.4 versus 6.2, P less than 0.05. Due to a high success rate of IVF but at the same time a high frequency of no cleavage in cases of unexplained infertility or male subfertility, we recommend IVF as the primary procedure in infertile couples with patent Fallopian tubes.

Entities:  

Mesh:

Year:  1990        PMID: 2351708     DOI: 10.1093/oxfordjournals.humrep.a137086

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  IVF versus GIFT.

Authors:  I Craft; T al-Shawaf
Journal:  J Assist Reprod Genet       Date:  1992-10       Impact factor: 3.412

2.  In vivo fertilization procedures in infertile women with patent fallopian tubes: a comparison of gamete intrafallopian transfer, combined intrauterine and intraperitoneal insemination, and controlled ovarian hyperstimulation alone.

Authors:  T Abyholm; T Tanbo; P O Dale; O Magnus
Journal:  J Assist Reprod Genet       Date:  1992-02       Impact factor: 3.412

3.  The use of the stem pessary to facilitate transcervical embryo transfer in women with cervical stenosis.

Authors:  G N Frishman
Journal:  J Assist Reprod Genet       Date:  1994-04       Impact factor: 3.412

4.  The role of gamete intrafallopian transfer (GIFT) and tubal embryo transfer (TET) in the treatment of patients with patent tubes associated with male infertility factor.

Authors:  R Seracchioli; A Maccolini; E Porcu; A Borini; M Cattoli; P Ciotti; F Violini; C Flamigni
Journal:  J Assist Reprod Genet       Date:  1993-05       Impact factor: 3.412

5.  Methodology of human embryo transfer following assisted reproduction.

Authors:  S Friedler; A Lewin; J G Schenker
Journal:  J Assist Reprod Genet       Date:  1993-08       Impact factor: 3.412

6.  Vaginal bleeding and early pregnancy outcome in an infertile population.

Authors:  Z N Dantas; A P Singh; P Karachalios; R H Asch; J P Balmaceda; S C Stone
Journal:  J Assist Reprod Genet       Date:  1996-03       Impact factor: 3.412

Review 7.  In vitro fertilisation for unexplained subfertility.

Authors:  Zabeena Pandian; Ahmed Gibreel; Siladitya Bhattacharya
Journal:  Cochrane Database Syst Rev       Date:  2015-11-19

8.  In vitro fertilization (IVF): a review of 3 decades of clinical innovation and technological advancement.

Authors:  Jeff Wang; Mark V Sauer
Journal:  Ther Clin Risk Manag       Date:  2006-12       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.